Technical Study: Hospira, Alkermes, Theravance, and Celsion

LONDON, July 22, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Friday, July 19, 2013, shares in healthcare companies ended mostly higher even as the broader market ended on a mixed note after a few weak earnings reports from the tech sector. The major movers in the healthcare sector included Hospira Inc. (NYSE: HSP), Alkermes Plc (NASDAQ: ALKS), Theravance Inc. (NASDAQ: THRX), and Celsion Corporation (NASDAQ: CLSN). AAAResearchReports.com free coverage on HSP, ALKS, THRX, and CLSN is available upon registration at:

http://www.aaaresearchreports.com/register/

Shares in Hospira Inc. edged higher on Friday even as the broader market ended on a mixed note. The company's shares oscillated between $39.31 and $39.82 before finishing the day 0.91% higher at $39.78. A total of 947,084 shares were traded which is below the daily average volume of 1.03 million. Hospira's shares have gained 14.34% in the last one month, thus outperforming the S&P 500 which gained 6.26% in the same period. Moreover, the stock is currently trading near its 52-week high of $39.95. Download free technical research on HSP by signing up at:

http://www.AAAResearchReports.com/HSP072213.pdf

Alkermes Plc's stock rose sharply on Friday, extending its gains from previous trading sessions. The company's shares ended the day 2.87% higher at $31.18 after oscillating between $29.89 and $31.39. A total of 865,611 shares were traded which is below the daily average volume of 1.69 million. The company's shares have gained 5.23% in the last three trading sessions, and 14.59% in the past one month, thus outperforming the S&P 500. Furthermore, the stock is currently trading above its 50-day and 200-day moving averages. Register now and get access to free analysis on ALKS at:

http://www.AAAResearchReports.com/ALKS072213.pdf

Shares in Theravance Inc. moved lower on Friday, extending their losses for the week. The company's shares ended the day 0.49% lower at $38.75 after oscillating between $38.72 and $39.33. A total of 768,580 shares were traded which is below the daily average volume of 1.30 million. The company's shares fell by 7.94% last week as compared to a gain of 0.71% in the S&P 500. Despite last week's losses, Theravance's shares have gained 3.07% in the last one month.  Sign up and read our complimentary report on THRX at:

http://www.AAAResearchReports.com/THRX072213.pdf

Shares in Celsion Corporation surged on Friday, extending their gains for the week. The company's shares oscillated between $1.35 and $1.55 before finishing the day 16.49% higher at $1.42. A total of 14.26 million shares were traded which is above the daily average volume of 3.55 million. Celsion's shares gained 25.66% last week, thus outperforming the S&P 500. In the last three months, the stock has gained 78.62%, as compared to a gain of 8.80% in the same period. The free report on CLSN can be downloaded by signing up now at:

http://www.AAAResearchReports.com/CLSN072213.pdf

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE AAA Research Reports